Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 221

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Pharmacokinetic Interactions Augment Toxicities of Sirolimus/Cyclosporine Combinations

PODDER, HEMANGSHU, STEPKOWSKI, STANISLAW M., NAPOLI, KIMBERLY L., CLARK, JAMES, VERANI, REGINA R., CHOU, TING-CHAO, KAHAN, BARRY D.·2001·Journal of the American Society of Nephrology

Abstract

Abstract.: This study correlated the dynamic effects of sirolimus (rapamycin; RAPA) and cyclosporine (CsA) alone versus in combination to produce renal dysfunction, myelosuppression, or hyperlipidemia, with their corresponding blood and tissue concentrations. After salt-depleted rats were treated with RAPA (0.4 to 6.4 mg/kg per d) and/or CsA (2.5 to 20.0 mg/kg per d) for 14 d, the GFR, lipid levels, bone marrow cellularity, and CsA/RAPA concentrations in whole blood versus liver or renal tissues were measured, and the median effect model was used to discern the type of drug interactions. Compared with vehicle controls (1.98 ± 0.34 ml/min), GFR values were reduced only by large doses of drug monotherapy, namely RAPA (3.2 mg/kg per d = 1.2 ± 0.02 ml/min or 6.4 mg/kg per d = 1.3 ± 0.2 ml/min; both P < 0.01) or CsA (10.0 mg/kg per d = 1.2 ± 0.1 ml/min or 20.0 mg/kg per d = 0.8 ± 0.4 ml/min; both P < 0.01). In contrast, hosts that were treated with smaller doses of CsA/RAPA combinations showed more pronounced effects in reduction of GFR values: 2.5/0.4 mg/kg per d, modestly (1.5 ± 0.5 ml/min; P < 0.01); 5.0/0.8 mg/kg per d, moderately (0.23 ± 0.01 ml/min; P < 0.001); and higher-dose groups, markedly. The exacerbation of renal dysfunction seemed to be due to a pharmacokinetic interaction of RAPA to greatly increase CsA concentrations in whole blood and, particularly, in kidney tissue. In contrast, the pharmacodynamic effects of CsA to potentiate two RAPA-mediated toxicities—myelosuppression and increased serum cholesterol/low-density lipoprotein cholesterol—occurred independently of pharmacokinetic interactions. RAPA aggravates CsA-induced renal dysfunction owing to a pharmacokinetic interaction, whereas CsA produces a pharmacodynamic effect that augments RAPA-induced myelosuppression and hyperlipidemia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1681/asn.v1251059

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 221

Metadata

Authors
PODDER, H., STEPKOWSKI, S. M., NAPOLI, K. L., CLARK, J., VERANI, R. R., CHOU, T.-C., & KAHAN, B. D.
Venue
Journal of the American Society of Nephrology
Published
2001-05
Volume
12
Issue
5
Pages
1059-1071
ISSN
1046-6673 (ISSN-L)
OpenAlex
W2128257213
Cited by
221
References
1
FWCI
10.06
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pharmacokinetic Interactions Augment Toxicities of Sirolimus/Cyclosporine Combinations. https://app.cochat.ai/papers/10.1681/asn.v1251059
The paper
PODDER, H., STEPKOWSKI, S. M., NAPOLI, K. L., CLARK, J., VERANI, R. R., CHOU, T.-C., & KAHAN, B. D. (2001). Pharmacokinetic Interactions Augment Toxicities of Sirolimus/Cyclosporine Combinations. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.v1251059

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.